Is the SBIR grant program is unfairly towards small biotech companies

28 patient organizations joined BIO in asking Congress to restore eligibility to venture-backed biotech companies to “help innovative research move forward in order to foster breakthrough cures.”

Under the SBA’s new rules, companies with more than 50 percent of their backing from venture capital can’t compete for grants

 Biotech industry calls on Congress to change grant program

%d bloggers like this: